Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,057.99
+9.190.45%
Number of Gainers:708
Number of Losers:295
Number of Flat:21
PE:- -
High:2,061.27
Open:2,048.81
Low:2,048.55
Close:2,048.80
Volume:4.88B
Turnover:622.11B
Market Cap:95.90T
Float Cap:89.78T

Loading ...

StorageVault Completes CAD 81.55 Million Acquisition of Four Storage Assets

Reuters
·
Aug 26

Analysts Have Conflicting Sentiments on These Materials Companies: Celanese (CE) and Gold Fields (GFI)

TIPRANKS
·
Aug 26

MPS Director Herbert Chang Sells 50 Common Shares Worth $64,078.5

Reuters
·
Aug 26

Analysts Offer Insights on Communication Services Companies: AppLovin (APP) and E. W. Scripps Company Class A (SSP)

TIPRANKS
·
Aug 26

Analysts Offer Insights on Consumer Cyclical Companies: Gogoro (GGR), Royal Caribbean (RCL) and Oxford Industries (OXM)

TIPRANKS
·
Aug 26

Abercrombie & Fitch Co. - Share Repurchases Increased to at Least $500 Mln

THOMSON REUTERS
·
Aug 26

Abercrombie & Fitch: Outlook FY 2026 Net Sales Growth Around 5%

THOMSON REUTERS
·
Aug 26

Abercrombie & Fitch Co. - Estimates Q3 & Full Year 2026 Tariff Refunds Impact on EPS, Inclusive of Interest, to be $0.35 and $2.10, Respectively

THOMSON REUTERS
·
Aug 26

Abercrombie & Fitch Co.: in Q2 Saw Improving Trends in Emea

THOMSON REUTERS
·
Aug 26

Abercrombie & Fitch Q2 Sales USD 1,266.689 Million VS. Ibes Estimate USD 1,248 Million

THOMSON REUTERS
·
Aug 26

Abercrombie & Fitch Q2 Adjusted EPS USD 4.17 VS. Ibes Estimate USD 1.99

THOMSON REUTERS
·
Aug 26

Abercrombie & Fitch Outlook Q3 EPS USD 2.9-3.2

THOMSON REUTERS
·
Aug 26

Abercrombie & Fitch Co. - Q2 EPS Includes Ieepa Tariff Refund Impact of $1.75 Benefit

THOMSON REUTERS
·
Aug 26

Abercrombie & Fitch Co. Reports Second Quarter Fiscal 2026 Results

THOMSON REUTERS
·
Aug 26

Better, Coinbase Announce General Availability of First Token-Backed, Conforming Mortgage to Expand Homeownership Access for a New Generation of Mortgage Borrowers

THOMSON REUTERS
·
Aug 26

BridgeBio Announces First Participant Dosed in Ascend-Attr, a Phase 3B/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in Attr-Cm

THOMSON REUTERS
·
Aug 26

Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026

GlobeNewswire
·
Aug 26

Woodside (ASX:WDS) Shares Drift As Profit Strength Meets Project Risk

Simply Wall St.
·
Aug 26

Corpay CEO and Chairman Ronald Clarke Disposes of USD 100.98 Million in Common Shares

Reuters
·
Aug 26

Meta Rises on Report of Settlement Talks

Reuters
·
Aug 26